One contribution of 12 to a theme issue 'Synthetic glycobiology'. Lectins are a widespread group of sugar-binding proteins occurring in all types of organisms including animals, plants, bacteria, fungi and even viruses. According to a recent report, there are more than 50 lectin scaffolds ( Pfam), for which three-dimensional structures are known and sugar-binding functions have been confirmed in the literature, which far exceeds our view in the twentieth century (Fujimoto et al. 2014 Methods Mol. Biol. 1200, 579-606 (doi:10. 1007/978-1-4939-1292). This fact suggests that new lectins will be discovered either by a conventional screening approach or just by chance. It is also expected that new lectin domains including those found in enzymes as carbohydrate-binding modules will be generated in the future through evolution, although this has never been attempted on an experimental level. Based on the current state of the art, various methods of lectin engineering are available, by which lectin specificity and/or stability of a known lectin scaffold can be improved. However, the above observation implies that any protein scaffold, including those that have never been described as lectins, may be modified to acquire a sugar-binding function. In this review, possible approaches to confer sugar-binding properties on synthetic proteins and peptides are described.
Introduction
Francois Jacob described in The possible and the actual how our imaginations cannot completely overcome our past experiences as evidenced by the depictions of aliens in scientific fiction and chimeric creatures in Greek mythology [1] . Likewise, the protein structures that we design and produce in vitro will have limitations, probably because we are likely to use existing protein scaffolds as starting materials and templates when we perform mutagenesis and engineering experiments. How to 'create' lectins from an engineering viewpoint is a theme of this review. However, for this discussion, it is worth first mentioning their counterpart or receptor molecules, glycans. Glycans are regarded as the third group of biopolymers for which rich structural diversity and biological information is available, following nucleic acids (DNA and RNA) and proteins ( polypeptides). Although the latter two are 'linear' molecules, in which component molecules (i.e. nucleotides and amino acids, respectively) are connected by a single linkage pattern, the former (glycans) are often branched with multiple linkage isomers. Thus, unlike DNA and peptides, it is difficult to develop a systematic principle to facilitate automated sequencing and synthesis for glycans. Even if this can be achieved, there is an additional complication. Glycans usually exist as glycoconjugates, glycoproteins, proteoglycans and glycolipids, rather than existing in a free state. In the case of glycoproteins, there are also further structural types, largely divided into N-glycans and O-glycans, which are biosynthesized using different construction principles by different sets of glycosyltransferases, although their non-reducing terminal modifications (e.g. sialylation, fucosylation, sulfation, etc.) are largely identical [2] .
The total set of these biomolecules, i.e. DNA, protein and glycan, in a biological species is called its genome, proteome and glycome, respectively. Soon after the word proteome appeared in 1995 [3] , the word glycome was coined by a few glycoscientists simultaneously at the end of the twentieth century [4] [5] [6] . Although the central dogma defines a direction of genetic information flow from DNA to protein via an intermediate molecule, RNA, most of the resultant proteins do not remain 'naked' but are subject to extensive post-translational modifications. Among these modifications, glycosylation is the most dominant and even complex. In fact, all biological organisms spend much effort not only on the synthesis of glycans but also on their recognition or 'decoding' by a variety of carbohydrate-binding proteins or lectins (historically called haemagglutinin or agglutinin), and on their degradation by a series of endo-and exo-glycosidases. The molecular mechanisms of these biological phenomena involving glycans and their functions are not fully understood. However, the fact that there are a considerable number of glycan-related genes in our genome (e.g. https://www.ccrc.uga.edu/~more-men/glycomics/) implies that cell-cell communication events are fundamental, and thus essential for various biological phenomena including development, immunity, tumorigenesis and infection. This central role may be due to the origin of glycans: they are synthesized within the lumen of the endoplasmic reticulum and the Golgi apparatus in eukaryotes for secretion. In this context, a backbone structure of peptidoglycans in prokaryotes consisting of repeats of the disaccharide unit (MurNAcb1-4GlcNAcb1-4) seems meaningful, considering that MurNAc is a C3-lactate ester of GlcNAc involved in coordinating linear chitin (GlcNAcb1-4GlcNAcb1-4-) polymers to reinforce the inner membrane of bacteria. Hence, it is possible to speculate that toxic ammonia, a possible biproduct generated from amino acid degradation, is neutralized by cheap and common materials, Glc and acetate (Hiroko Shirai, Okayama University, personal communication), along with the common strategy of 'bricolage' [1] .
Lectins are a comprehensive name assigned to carbohydrate-binding proteins. Although their definitions have significantly changed in the history of lectin researches [7] [8] [9] , now a broader range of proteins are considered as lectins (often characterized as haemagglutinins) or proteins containing carbohydrate-binding domains (rarely characterized as haemagglutinins). For the latter extension, a carbohydratebinding module (CBM) is involved in supporting enzymatic reactions in glycan synthesis and degradation. Anyway, they are specifically directed to parts of glycan structures and participate in a wide range of biological phenomena. They not only recognize particular glycan epitopes but also cross-link or agglutinate these structures carried on various glycoconjugates. This results in evaluating and switching biological signals in a time-and space-specific manner. Thus, lectins are often referred to as 'decipherers' of the complex features of glycans, i.e. 'glycocodes' [10] [11] [12] [13] .
Current state of the art of lectin engineering
Glycomimetics is a recent trend of glycan engineering, which are pharmaceutical drugs mimicking glycan structures with improved properties, represented by zanamivir (neuraminidase inhibitor of influenza virus A [14] ), rivipansel ( pan-selectin inhibitor [15] ), eliglustat (inhibitor of glycosylceramide synthase [16] ) and canagliflozin (inhibitor of sodium-glucose co-transporter 2) [17] . On the other hand, how does lectin engineering compare with glycan engineering? Here the question is 'Are we capable of creating artificial lectins inspired by nature?' If it is the case, we must be able to create artificial lectins based on arbitrary designs with variable production systems. Regrettably, this is not currently easily done. Nevertheless, it is still a promising goal that may be achieved after dozens of years of research and development.
From a technical viewpoint, there are a few strategies to perform lectin engineering: (i) protein engineering, (ii) nucleic acid (aptamer) engineering and (iii) chemical engineering using e.g. boronate. There are many studies using these techniques; however, their application to lectin engineering is largely limited compared with other functional proteins, e.g. enzymes. Although, there are a significant number of pioneering works of lectin engineering targeting the specificity of an animal C-type lectin [18, 19] and a bacterial lectin [20, 21] . Probably, the first such attempt was made by Yabe et al.
(described in detail below) [22] , who tailored a novel sialic acid-binding lectin from an R-type galactose-binding protein using random mutagenesis and a ribosome-display method under the concept of 'natural evolution-mimicry' [23] . Since their work, a significant number of reports of protein engineering base lectin engineering have come out of different laboratories [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] . Aptamer and chemistry-based lectin engineering are also promising and challenging. Although they might still be in the initial stages of development, Ferreira et al. succeeded in producing a 25-nt aptamer specific for MUC1-5-TR-aGalNAc (Tn) [37] , and Bie et al. developed a new strategy for the preparation of lectin-like molecules, named molecularly imprinted polymers [38] .
In the following sub-sections, the authors describe a few examples of protein engineering studies performed in the authors' laboratory to note how the derived results were beyond their expectation: the first two were conducted on an R-type lectin domain, EW29Ch, to which random point mutagenesis was introduced by error-prone polymerase chain reaction followed by expression screening using ribosome display (outline summarized in figure 1) (for a review, see [39] ), while the third was based on site-directed mutagenesis targeting sugar-binding residues of a mushroom galectin, ACG, and led to an unexpected result.
2.1. Case 1: engineering a Gal-specific lectin to a Siaa2 -6Gal-specific one via mutagenesis Using a method developed by themselves [22] , Yabe et al. attempted to engineer a Sia-specific lectin from a Gal-specific lectin using the hypothetical concept of evolutionary mimicry, in which Gal is regarded as a late-comer saccharide compared to Fru, Glc and Man, and thus lectins specific for these saccharides emerged in the same order over the course of evolution. On the other hand, Sia-binding lectins are believed to have evolved from a Gal-specific lectin, firstly because Sia is always additive to Gal (a Gal modifier), and secondly because it is a 'bricolage' product derived from Man(NAc) coupled with pyruvate [23] . As a protein scaffold, Yabe et al. chose the C-terminal half domain of an earthworm 29-kDa lectin (EW29Ch). EW29Ch is a 14.5-kDa Gal-specific R-type (ricin B-chain-like) lectin, and its recombinant protein can easily be produced in a royalsocietypublishing.org/journal/rsfs Interface Focus 9: 20180068 conventional bacterial expression system [40] . Random mutagenesis was performed over the full-length cDNA, and the in vitro-translated product was selected by fetuin-agarose beads, which are rich in a2-6sialylated triantennary N-glycans. After 4 rounds of screening, they selected 40 clones for sequencing and found that 2 were completely identical at the nucleotide level, indicating that they were the mutants with a new specificity for a2-6Sia. The translated amino acid sequences showed six mutations at the amino acid level, one of which was located in an a-subdomain, and the other five in a g-subdomain (figure 2a). According to previous works, both subdomains have been shown to have Gal-binding activity in the wild-type by NMR [41] and crystallography analyses [42] , while the b-subdomain has no such activity (figure 2a).
Detailed oligosaccharide specificity for the derived mutant named SRC (Sia-specific R-type lectin EW29Ch) was investigated by frontal affinity chromatography analysis [43] . It was found that SRC binds three to four times more preferentially to a2-6Sia-terminated N-glycans than bGal-terminated glycans, while the wild-type EW29Ch could not bind to a2-6Sia-terminated N-glycans at all. Nevertheless, the total affinity of SRC was more than one order of magnitude lower than the wild-type [22] . To investigate the molecular details, Yabe et al. performed a crystallographic analysis of SRC and found that the g-subdomain had lost sugar-binding activity by the introduction of five mutations. On the other hand, the a-subdomain maintained the bGal-binding ability and had acquired a novel affinity to a2-6Sia with the sacrifice of the g-subdomain. The loop region containing E237G in the g-subdomain underwent a significant structural change, from a partially folded to an extended loop structure, probably due to one or more of the five mutations; i.e. I227N, D230G, I231V, E237G or G239S. Of these, the D230G change is crucial considering its involvement in hydrogen bonding to bGal, and with the loss of hydrogen bonding, the supportive stacking interaction by Trp to the hydrophobic B face of bGal is also disrupted. While this seems to make the D230G mutation fatal, this structural change in turn moves the Ser239 side chain (by G239S mutation) closer to the C1-carboxyl group of a2-6Sia to make a novel hydrogen bond, while the E148G substitution facilitates a new hydrogen bond between Gly148 backbone carbonyl group and C9-OH group (figure 2b).
To summarize, by using the ribosome display method followed by four selection cycles with fetuin beads, bGal-specific EW29Ch was modified into an a2-6Sia-specific lectin. However, the derived mutant SRC is an imperfect Sia-specific lectin as it still binds to bGal (lactose). This result is quite unexpected in that with the sacrifice of the functional g-subdomain, the a-subdomain has acquired a novel specificity toward a2-6Sia-Gal, and that while the binding affinity to lactose remained the newly obtained Sia-binding affinity is merely of the order of 10 4 M 21 in K a . This is obviously due to the loss of multivalency, in other words, 'trade-offs'. This failure was improved to some degree by tandemizing the 14.5-kDa structure with a short linker peptide. The resultant SRC2 showed a substantial affinity towards a2-6sialylated N-glycans on a level almost comparable to natural a2-6Sia-specific lectin from Sambucus sieboldiana (SSA), i.e. of the order of 10 26 M in
2.2. Case 2: engineering Gal-specific lectin to 6 0 -sulfo-Gal-specific mutant
Because the hit ratio in the above experiment was as low as 5% (2 positive clones among 40), Hu et al. attempted to improve the strategy in two ways [45] . The first was selection using biotinylated multivalent carbohydrate polymers, and the second was using a high-throughput screening system with a glycoconjugate microarray [46] , in which the same glycoconjugates are used for the selection procedure. royalsocietypublishing.org/journal/rsfs Interface Focus 9: 20180068 there was no useful lectin specific for 6S-Gal despite its potential as a marker for various diseases [45] . After 2 rounds of selection using 6-sulfo-N-acetyllactosamine (6 0 S-LN) polymer as a probe, 20 clones were randomly selected and sequenced (figure 3a). Fourteen of the clones (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) were found to carry the mutation E20 K in the a-subdomain in common. These mutants were expressed in E. coli, and the 12 that successfully expressed (1-8 and 15-18) were subjected to sugar-binding analysis by a glycoconjugate microarray. Eight of the 12 mutants (1-8) carrying the mutation E20 K exhibited a specific affinity for 6 0 S-LN, whereas the remaining clones (15) (16) (17) (18) without this mutation lacked this activity (figure 3b). Quantitative frontal affinity chromatography analysis of two representative clones (1 and 4) showed that both mutants and the wild-type EW29Ch displayed a similar affinity to Gal-terminated glycans, i.e. in terms of K d , 2 Â 10 25 M, while the two mutants exhibited a greater affinity to [45] . Notably, the wild-type EW29Ch did not show affinity to this sulfated glycan, and the mutants did not show detectable affinity to either of 3S-Gal, Neu5Aca2-6-Gal or 6S-GlcNAc. Comparison of the affinity toward a panel of 129 pyridylaminated oligosaccharides confirmed that EW29Ch and the mutant have almost identical binding profiles except for the recognition of the terminal 6S-Gal moiety. However, it turned out that this was not the creation of a 'novel' 6S-Gal-binding ability in R-type lectins (see below). During the course of preparing the paper, some R-type lectins were found to have another basic amino acid, Arg, at the position corresponding to E20 K. These include the toxic ricin B-chain, its non-toxic isolectin RCA120 and mistletoe lectin (figure 4). The preferential enrichment of E20 K rather than E20R in this study was considered to be due to statistics. The single-nucleotide mutagenesis (GAR to AAR) required to cause the change to E20 K is more probable than the dual nucleotide mutagenesis (GAR to CGN/AGR) required to cause the E20R mutation. In fact, we confirmed that E20R showed an affinity for 6S-Gal binding comparable to that of E20 K. On the other hand, E20H had only a limited affinity for 6S-Gal. Interestingly, in our previous paper reporting on the glycoconjugate microarray, we noted that RCA120 showed substantial binding to 6 0 S-LN [45] , although this specificity had been undescribed until 2011, when a Chinese group published a paper reporting that RCA120 binds to sulfated glycans, referring to our paper [47] .
To summarize, the reinforced ribosome display method proved to be very effective and powerful for screening with a high hit ratio (70%) even after only 2 rounds of screening. However, all of the derived mutants maintained the original b-Gal-binding activity, while their affinity to 6S-Gal was two to three times higher than to Gal. Thus, the creation of a stringently 6S-Gal-specific lectin is very difficult and potentially impossible using current point mutagenesis procedures with the known protein scaffold. Eventually, we came to the same endpoint as the natural product RCA120. In this context, our mutagenesis experiments seem to have just found their way home, i.e. to Nature.
2.3. Case 3: engineering unexpected novel specificity in a mushroom galectin ACG (Agrocybe cylindracea galectin) has broader specificity than other galectins: it binds to a wider range of b-galactosides, including 3 0 -sialyllactose (Neu5Aca2-3Galb1-4Glc), 3 0 -sulfolactose (sulfo-3Galb1-4Glc), A-tetrasaccharide (Fuca1-2(GalNAca1-3)Galb1-4Glc) and Forssman pentasaccharide royalsocietypublishing.org/journal/rsfs Interface Focus 9: 20180068 (GalNAca1-3GalNAca1-3Galb1-4Galb1-4Glc) . This is considered to be due in part to the C3 0 -modification of a basic recognition disaccharide, lactose, because it is a common feature for galectins to exhibit a variety of sugarbinding specificities [48] . However, this broad sugar specificity of ACG cannot simply be attributed to the C3 0 substitution of lactose, because it shows substantial binding to the Forssman disaccharide GalNAca1-3GalNAc in a glycoconjugate microarray analysis, which is not a b-galactoside [49] . As a structural feature distinct from other galectins, ACG has an extra loop region between the F2 and S3 b-strands, i.e. Gly-SerPro-Asn-Asn (Asn46), which most of the galectins lack (figure 4a). Notably, Asn46 is involved in the b-galactoside binding, which compensates for the lack of another Asn conserved in other galectins [50] .
Hu et al. conducted comprehensive mutagenesis targeting hydrophilic amino acid residues involved in the sugar-binding function of ACG, aimed at narrowing this broad specificity [49] . They included the evolutionarily conserved His62, Arg66, Asn75 and Glu86, as well as the non-conserved Asn46. The results for Asn46 were quite unexpected. When Ala was substituted for these amino acids, the resulting mutants almost completely lost sugar-binding activity to b-galactosides except for N46A, which showed restricted specificity to GalNAca1-3Gal/GalNAc-containing oligosaccharides, but could no longer bind b-galactosides, such as lactose/LacNAc [49] .
Based on a previous crystallography analysis [50] , Hu et al. hypothesized that ACG takes one of two different structural conformations depending on the cis-trans isomerization of Pro45, each of which corresponds to different specificities. They found that all of the 18 N46X mutants had almost identical binding profiles to N46A. They all showed selective binding to GalNAca1-3Gal/GalNAc, but not to b-galactosides, such as lactose/LacNAc. This implies that Asn46 compensates for the lack of an evolutionarily conserved Asn65 (substituted with Ala in ACG). However, this function requires the cis conformation of Pro45. On the other hand, all of the N46X mutants exclusively take on the trans conformation, which is sterically more favourable, but in this case makes binding to b-galactosides impossible, hence creating another conformation responsible for a unique specificity to Forssman disaccharide, GalNAca1-3GalNAc, or blood group A-tetrasaccharide, Fuca1-2(GalNAca1-3)Galb1-4GlcNAc. If this is the case, P45X mutants, which exclusively prefer a trans to cis conformation, should show the same binding profile as the N46X mutants described above. Consistent with this hypothesis, a P45A mutant had essentially the same binding profile as that of N46A, with selective binding to A-tetrasaccharide and Forssman disaccharide, but no binding to lactose/LacNAc [49] .
A conclusive study was performed by Kuwabara et al. who analysed the crystal structures for both the wild-type and mutant ACG (N46A) in their free forms, and in complexes with either lactose or A-tetrasaccharide [51] . The loop region, including residues 44-46, was found to undergo a drastic conformational change upon cis-trans isomerization at Pro45 (figure 4b). To summarize: (i) Pro45 adopts the cis conformation when wild-type ACG is complexed with lactose, while it takes on the trans conformation in a free state. (ii) Wild-type ACG also adopts the trans conformation when it is complexed with A-tetrasaccharide. (iii) The trans conformation is maintained by the N46A mutant, both in its free state and when complexed with A-tetrasaccharide. Interestingly, a similar redundant loop region is also conserved in some other mushroom galectins, such as A. aegerita galectin (AAG), Laccaria amethystina galectin (LAG), L. bicolor galectin isolectins 1-3 (LBG1-3) and Coprinopsis cinerea galectin isolectins 1-3 (CCG1-3). Among these, however, only AAG from the same genus (ACG) contains the 'Pro-Asn' motif. In fact, Pro43 in AAG (corresponding to Pro45 in ACG) adopts the cis conformation in the complex with lactose (PDB ID: 2ZGM).
These observations provide the basis for an interesting discussion of a possible evolutionary pathway for ACG and its related galectins. However, it is quite difficult to take into account in advance the possibility of cis-trans conformational change upon mutagenesis. Obviously, we are still far away from the goal for both lectin design and engineering.
3. Hypothesis: can lectins be produced from any protein scaffold? [53] , the 70-kDa component of the haemagglutinin (HA) complex of Clostridium botulinum type C toxin (HA70; PF17993) [54] , the Mumpus virus attachment protein haemagglutinin-neuraminidase (MuV-HN; PF00423) [55] , a 15.5-kDa mannose-specific lectin from the oyster Crassostrea gigas (CGL1; PF11901) [56] , a 18.5-kDa lectin from the sea anemone Anthopleura japonica (AJLec; Pfam ID not assigned yet) [57] and a fungal lectin named tectonin binding to O-methylated glycans [58] . On the other hand, these lectin domains are often found as one part of a more complex protein architecture, i.e. carbohydrate-recognition domains (CRDs) or CBMs. A typical case is the recent finding of GlcNAc-binding function in the N-terminal stem domain of POMGnT-1, the biological significance of which had been unknown until Kuwabara et al. happened to find the sugar-binding ability of this domain in the course of the crystallography of the enzyme using a glycopeptide as substrate [51] . Thus, more than 50 protein scaffolds containing a lectin domain (CRD/CBM), covering all biological taxonomies, i.e. bacteria, fungi, animals, plants and viruses, have been identified, and this number is still increasing ( figure 5) .
From a structural viewpoint, it does not seem that there is a particular requirement for a protein scaffold to 'become' a lectin. While it is true that many lectin domains are rich in b-structure represented by b-prism, b-trefoil, b-propeller and b-sandwich royalsocietypublishing.org/journal/rsfs Interface Focus 9: 20180068 folds, it is reasonable to take advantage of b-strands to make a hydrogen-bond network, which usually involves a repeat of hydrophilic and hydrophobic side chains of amino acid on the strand that can more easily form a series of hydrogen bonds. Examples include three evolutionarily conserved hydrophilic residues on the S4 strand of galectins (PF00337): e.g. His44-Phe45-Asn46-Pro47-Arg48 in the case of human galectin-1 (italicized amino acid residues are involved in hydrogen bonding to ligand saccharides) [59] . However, this is not an absolute requirement for a lectin scaffold, considering that there are a significant number of lectin domains poor in b-structure, such as C-type lectins (PF00059), Ym1 lectins (PF00704), and a-mannosidase-like (or M-type) lectins (PF01532).
Thus, if there are no particular structural constraints for lectin scaffolds, it is possible to hypothesize that any protein scaffold, even those that have never contained a lectin domain, could evolve into a functional lectin molecule in the course over time. If this is true, even a wholly artificial protein can be created or engineered into a lectin. If this is the case, we could provide more useful lectins for various fields, e.g. medical, industrial, environmental and food sciences. While such an approach has not yet been followed it will become a trend in protein engineering and molecular evolutionary science in parallel to glyco-engineering. In this context, it is fundamentally important to assess the potential of each protein/lectin scaffold in terms of sugar-binding specificity and multivalent features: one protein scaffold may be unable to recognize b-galactoside but rather prefer a-galactoside, while another scaffold may suit the recognition of a2-6Sia rather than a2-3Sia. With the aid of computer science and artificial intelligence, the potential of each protein scaffold in terms of sugar-binding specificity as well as cross-linking features will be elucidated in a more systematic way.
Possible procedures for creating artificial lectins
There are many strategies to create artificial proteins and protein complexes, although their applications to lectin engineering are still limited. According to Arai et al. [60] , typically one of 14 strategies is used, i.e. (i) random-sequence library-directed evolution, (ii) secondary structure element library, (iii) binary code, (iv) nanohedra, (v) protein nano-building block, (vi) metal-templated interface redesign, (vii) protein-metalorganic frameworks, (viii) parametrical design of a-helical coiled coil, (ix) fully automated sequence selection, (x) computational design of a novel globular protein fold, (xi) principles for designing ideal protein structures, (xii) protein design by tandem repeating a structural motif, (xiii) design of royalsocietypublishing.org/journal/rsfs Interface Focus 9: 20180068 self-assembling protein complexes and (xiv) interface design for further assembles. These strategies are further categorized based on two criteria: first, whether they are based on combinatorial and protein engineering methods or rational and computational methods, and second where in the hierarchy of structures, i.e. primary, secondary, tertiary, quaternary and supra-quaternary structures, they focus [60] . From a statistical viewpoint, protein folding is quite unsuccessful (a success rate , 10
210
) when using a random-sequence polypeptide library [61] . Furthermore, the success rate of artificial functional proteins from a random-sequence library was roughly estimated at 10 211 in a study on artificial proteins with ATP-binding activity [62] . Therefore, a large library size and an appropriately high-throughput screening method will be necessary to create artificial lectins from combinatorial polypeptide libraries. Rational and computational approaches to protein design have seen remarkable development in recent years with advances in computer science [63] . Advanced methods for computational design of ligand-binding proteins using the Rosetta design software suite were reported by Baker's group [64, 65] . In the near future, these computational methods may be applied to the de novo design of artificial lectins.
It is important to keep in mind that lectins often have multivalency in various forms, and thus have historically been characterized as agglutinin as a result of cross-linking homotypic cells such as erythrocytes and leucocytes. There are several strategies used to exert multivalency. In the case of galectins, their multivalent features toward bGal-bindingcontaining conjugates are based on their different protein architectures: the 'proto' type exists as dimers, and thus cross-link with homologous counterpart molecules potentially on other cells, the 'chimera' type forms pentameric assemblies via their N-terminal non-lectin domain, and the 'tandemrepeat' type recognizes significantly different glycan ligands [66] . In addition, a recent trend in protein engineering aiming at artificial multimeric protein complexes is based on the idea of composing artificial fusion proteins assembled to form larger symmetric architectures [67] using nanohedra [68] and protein nano-building blocks [69, 70] . For example, nanostructures of a barrel-shaped hexamer and a tetrahedron-like dodecamer self-assembled from protein nano-building blocks were reported by Kobayashi et al. [69] . Quite curiously, the structures of a hyperstable 60-subunit protein icosahedron [71] and a truncated icosahedral protein composed of 60-mer fusion proteins (TIP60) [72] look like a virus particle and a soccer ball, respectively: once again the authors found the way home and produced nature mimetics. These strategies can be applied to create multimeric complexes of artificial lectins.
A possible approach to synthetic peptic lectins
Considering there are a significant number of small lectin domains, it is also possible to assume that synthetic lectins can be constructed based on peptide chemistry. Examples of these small domains found in nature include subdomains of R-type lectins (b-trefoil fold, PF00652), subdomains of jacalin-related lectins (b-prism I fold, PF01419), subdomains of GNA-related lectins (b-prism II fold, PF01453), subdomains (b-trefoil fold, PF07463) of ACA-related lectins, and hevein-type chitin-binding lectins (hevein-like Cys-knot motif fold, PF00187). Although the subdomains are relatively small (35-45 amino acids), expression of individual subdomains is usually unsuccessful. This may be attributed, at least in part, to the high content of disulfide bonds (up to 20%), which is considered necessary to stabilize a compact structure. Therefore, maintaining both peptide foldability and solubility is the most critical if challenging issue in the creation as well as the engineering of peptic lectins. SHL-I from spider venom, consisting of only 35 amino acids, may represent the smallest natural lectin investigated so far (Cys-knot motif fold, PF07740); it also has a compact fold maintained by three pairs of disulfide bonds. Thus, above described de novo synthetic procedures considering both foldability and functionality have the same issues as synthetic peptic lectins. royalsocietypublishing.org/journal/rsfs Interface Focus 9: 20180068
It is also important to note that small peptic lectins should have more difficulty in selectivity and affinity toward target glycans because their structures are much simpler than proteins (this is an inherent drawback). A possible approach to overcome this difficulty is peptide modification by pinpoint chemistry (figure 6). The figure illustrates a strategy to introduce a chemical modifier, an amino sugar-oxazoline derivative (e.g. GlcNAc-oxazoline), into the primary amino group(s) of an arbitrary peptide. The reaction to generate an imidazoline is selective under the right conditions (pH 9, 308C), and under the same alkali conditions but at a higher temperature (408C) it gradually converts to an imidazole [73] . Notably, the resultant imidazole is endowed with the following properties, which are key for synthetic peptic lectins. It has multiple chiral centres equipped with multiple hydroxyl groups to increase both solubility and complexity, where we can choose various amino sugars differing in chirality. Moreover, these multiple hydroxyl groups together with a single imidazole group would preferably participate in specific interactions with particular types of saccharides via an extensive hydrogen network. The viability of the proposed strategy remains unproven and proof-of-concept experiments are necessary for future work for synthetic lectins.
Concluding remarks
Protein engineering aiming at producing artificial lectins has just started, and thus is still challenging. In this context, we must continue learning more about natural lectins. However, the development of artificial lectins will help explore the application of lectins to various fields, not only for pure science but also industrial, medical and even unexpected fields such as intelligent glues [74] . To achieve this, multidisciplinary collaboration is keenly required [75] , especially among glycoscientists and synthetic glycobiologists, because they can systemize all the necessary steps of glycoscience; to not only analyse and design but also synthesize even more complex and intelligent materials [76] .
